2K12HD001281/HD/NICHD NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2010	1
2011	1
2012	1
2024	0

Page 1

Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression.

Karam AK, Santiskulvong C, Fekete M, Zabih S, Eng C, Dorigo O. Karam AK, et al. Cytoskeleton (Hoboken). 2010 Aug;67(8):535-44. doi: 10.1002/cm.20465. Cytoskeleton (Hoboken). 2010. PMID: 20607860 Free PMC article.

Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells.

Fekete M, Santiskulvong C, Eng C, Dorigo O. Fekete M, et al. Anticancer Res. 2012 Feb;32(2):445-52. Anticancer Res. 2012. PMID: 22287731

Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.

Santiskulvong C, Konecny GE, Fekete M, Chen KY, Karam A, Mulholland D, Eng C, Wu H, Song M, Dorigo O. Santiskulvong C, et al. Clin Cancer Res. 2011 Apr 15;17(8):2373-84. doi: 10.1158/1078-0432.CCR-10-2289. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year